查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999468

吸入式一氧化氮輸送系統市場：依技術、輸送裝置、輸送方式、應用、最終用戶和通路分類－2026-2032年全球市場預測

Inhaled Nitric Oxide Delivery Systems Market by Technology, Delivery Device Type, Mode Of Delivery, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，吸入式一氧化氮輸送系統市場價值將達到 3.414 億美元，到 2026 年將成長至 3.7933 億美元，到 2032 年將達到 6.9118 億美元，複合年成長率為 10.60%。

主要市場統計數據
基準年 2025 3.414億美元
預計年份：2026年 3.7933億美元
預測年份 2032 6.9118億美元
複合年成長率 (%) 10.60%

全面介紹吸入式一氧化氮輸送系統，概述其在現代醫療保健環境中的臨床效用、技術進步和採購重點。

吸入式一氧化氮輸送系統在急性呼吸護理、心胸支持和新生兒重症監護中發揮著至關重要的作用，當傳統治療方法不佳時，它能提供靶向肺血管擴張。這些系統已從集中管理的鋼瓶發展到配備整合監測功能的先進電子發生器，從而實現了更精準的給藥、更高的安全性以及更廣泛的應用，包括門診和居家醫療環境。臨床醫生、醫院管理者和醫療設備製造商正在積極應對由臨床證據、技術創新和不斷發展的醫療保健服務模式所塑造的局面，這些模式優先考慮便攜性、安全性和易用性。

臨床創新、醫療保健的去中心化以及對證據的期望正在迅速改變吸入式一氧化氮解決方案的競爭格局和營運環境。

吸入式一氧化氮治療領域正經歷一場變革，其驅動力源自於臨床需求、技術進步以及醫療服務模式的轉變。電子發生器設計的進步改變了人們對便攜性、自動化監測以及與電子健康記錄整合等方面的預期，從而拓展了其在加護病房以外的應用範圍。同時，給藥精準度和警報系統的改進提高了安全標準，促使臨床團隊重新評估傳統的禁忌症，並探索針對特定呼吸系統和心臟疾病的早期介入策略。

本研究評估了美國關稅措施可能對 2025 年醫療設備的採購、分銷和採購慣例的多方面營運和供應鏈影響。

關稅等政策措施會對整個吸入式一氧化氮生態系統產生連鎖反應，改變零件的成本結構、進口趨勢和供應商的議價能力，而未必會改變其臨床應用原理。當關稅增加進口發生器、氣瓶或電子元件的接收成本時，製造商通常會重新考慮其籌資策略，例如將部分生產轉移回國內、實現供應商多元化或重新設計產品以減少對受關稅管制零件的依賴。這些供應側的調整會對採購計畫和合約談判產生後續影響，因為買家可能會要求更長的前置作業時間和更明確的供應保證。

詳細的細分分析揭示了應用、最終用戶、技術、設備類型、分銷管道和管理方法如何塑造差異化的臨床和商業策略。

細分市場分析清楚地突顯了每種應用、最終用戶、技術、給藥設備類型、分銷管道和給藥方法的臨床、營運和商業性需求。基於應用，市場研究涵蓋了廣泛的患者群體，從成人患者（不同的臨床路徑需要不同的給藥策略和監測強度，例如心臟手術中的低氧血症和肺動脈高壓）到新生兒患者（需要高度靈敏的控制和嚴格的安全功能，例如缺氧性呼吸衰竭和持續性新生兒肺動脈高壓）。兒童患者介於兩者之間，通常需要能夠適應其體型和給藥複雜性的設備。按最終用戶分類，涵蓋了優先考慮處理能力和易於設置的門診中心和診所、強調便攜性和看護者培訓的醫療保健項目，以及將與重症監護系統的整合和互通性視為重中之重的醫院。

美洲、歐洲、中東和非洲以及亞太地區各區域市場的市場動態和臨床部署模式，影響著進入、採購和商業化。

區域趨勢對臨床部署模式、報銷方式以及製造商和經銷商的策略重點有顯著影響。在美洲，實力雄厚的大學醫院以及心胸外科和新生兒專科項目集群是早期臨床部署和真實世界數據（REW）生成的中心，採購週期通常體現了與大規模醫療系統進行全面評估和談判的過程。因此，人們越來越關注設備互通性、服務支援模式以及能夠支援長期臨床研究的合約條款。

主要製造商和服務供應商如何透過安全性、證據生成和高度適應性的商業模式實現差異化並確保臨床應用。

吸入式一氧化氮輸送領域的主要企業正在多個方面進行投資，包括專注於安全性和易用性的工程設計、建造能夠證明臨床差異化的證據包，以及擴展服務組合以支持設備的長期運作。技術領導企業正專注於將監測、警報和與醫院資訊系統的互通性整合，以減輕臨床醫生的負擔並實現更安全的劑量調整通訊協定。專注於氣瓶解決方案的競爭對手則透過最佳化供應物流和為尚未廣泛採用電子產生器的醫療機構提供強大的支援網路來維持其市場地位。

產業領導者可以實施的可操作策略舉措，以加速採用、增強韌性，並在複雜的醫療保健系統中展現臨床和經濟價值。

產業領導者應優先考慮一系列切實可行的舉措，以鞏固市場地位、提升臨床影響力並降低營運風險。首先，投資於完善的上市後證據項目，不僅要衡量生理終點，還要衡量營運結果，例如住院時間、再入院率和看護者負擔。這些數據將為報銷談判和醫院採購決策提供支援。其次，建構靈活的經營模式，以滿足客戶偏好。這應包括資本租賃、管理服務和基於結果的合約等選項，以分散風險並促進長期夥伴關係。第三，增強設備互通性和數位化整合，以減輕醫療專業人員的工作量，並促進資料收集，從而推動品質改進舉措。

我們採用嚴謹的混合調查方法，結合臨床訪談、醫療設備技術分析和監管審查，以確保平衡且可操作的見解。

本研究採用混合方法，結合定性專家訪談、醫療設備規格分析、監管文獻回顧以及同行評審的臨床證據，以全面了解吸入一氧化氮給藥的現狀。研究透過對新生兒、兒童和成人心肺專科的臨床醫生、急診和門診醫療機構的採購經理以及醫療設備製造商和分銷商的高管進行結構化訪談，獲得了關鍵見解。這些觀點與醫療設備技術文件和監管申報文件進行了交叉比對，以評估其安全性、互通性和按司法管轄區分類的器械分類。

整合是將臨床需求、技術趨勢和組織策略連結起來的結論，可作為實施和長期規劃的指南。

吸入式一氧化氮輸送系統正處於臨床需求、技術成熟度和不斷演進的醫療服務模式交會的十字路口。這些設備的未來發展軌跡將持續受到以下需求的影響：提高安全性、增強便攜性以及獲得可證實的療效，從而證明其不僅在傳統醫院環境中，而且在門診和家庭環境中也具有更廣泛的應用價值。那些能夠開發出符合新生兒和成人重症監護環境實際情況的產品，同時投資於實證醫學研究和供應鏈韌性的製造商和供應商，將最有利於實現永續的臨床應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 吸入式一氧化氮輸送系統市場：依技術分類

  • 瓦斯罐
  • 電子發生器
    • 固定的
    • 攜帶式的

第9章 吸入式一氧化氮輸送系統市場（依輸送裝置類型分類）

  • 整合系統
  • 獨立型

第10章 依給藥方式分類的吸入式一氧化氮輸送系統市場

  • 永續的
  • 間歇性的

第11章 吸入式一氧化氮輸送系統市場：依應用分類

  • 成人版
    • 心血管手術中的低氧血症
    • 肺動脈高壓
  • 新生
    • 低氧性呼吸衰竭
    • 新生兒持續性肺動脈高壓
  • 兒童

第12章 吸入式一氧化氮輸送系統市場：依最終用戶分類

  • 門診部
  • 診所
  • 家庭醫療保健
  • 醫院

第13章 吸入式一氧化氮輸送系統市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上管道

第14章 吸入式一氧化氮輸送系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 吸入式一氧化氮輸送系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 吸入式一氧化氮輸送系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國吸入式一氧化氮輸送系統市場

第18章：中國吸入式一氧化氮輸送系統市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Air Liquide SA
  • Air Products and Chemicals, Inc.
  • Air Water Inc.
  • Bellerophon Therapeutics, Inc.
  • Beyond Air, Inc.
  • Chart Industries, Inc.
  • Dragerwerk AG & Co. KGaA
  • EKU Elektronik GmbH
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • INO Therapeutics LLC
  • International Biomedical Ltd.
  • Koninklijke Philips NV
  • Linde plc
  • Mallinckrodt Pharmaceuticals plc
  • Medtronic plc
  • Merck KGaA
  • Messer Group GmbH
  • NIOX Group plc
  • Novoteris, LLC
  • NU-MED Plus, Inc.
  • SLE Ltd.
  • Taiyo Nippon Sanso Corporation
  • Teleflex Incorporated
  • VERO Biotech LLC
Product Code: MRR-563BF1FCFB8B

The Inhaled Nitric Oxide Delivery Systems Market was valued at USD 341.40 million in 2025 and is projected to grow to USD 379.33 million in 2026, with a CAGR of 10.60%, reaching USD 691.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 341.40 million
Estimated Year [2026] USD 379.33 million
Forecast Year [2032] USD 691.18 million
CAGR (%) 10.60%

A comprehensive introduction to inhaled nitric oxide delivery systems that frames clinical utility, technological evolution, and procurement priorities for modern care settings

Inhaled nitric oxide delivery systems occupy a critical intersection between acute respiratory care, cardiothoracic support, and neonatal intensive care, offering targeted pulmonary vasodilation when conventional therapies are inadequate. These systems have evolved from centralized gas cylinders to advanced electronic generators with integrated monitoring, enabling more precise dosing, improved safety, and broader settings of use, including ambulatory care and home healthcare environments. Clinicians, hospital administrators, and device manufacturers are navigating a landscape shaped by clinical evidence, technological innovation, and evolving care delivery models that place a premium on portability, safety, and ease of use.

Transitioning from historical practice patterns, stakeholders are increasingly focused on optimizing patient outcomes while managing total cost of care. This requires a nuanced understanding of application-specific needs across adult, neonatal, and pediatric populations, as well as the comparative advantages of integrated systems versus standalone devices. As health systems emphasize continuity of care and shorter inpatient stays, delivery platforms that facilitate safe transition from hospital to home or outpatient settings are gaining strategic interest. Consequently, procurement decisions now balance clinical efficacy, operational workflow compatibility, and supply chain resilience, propelling a new wave of evaluation criteria among purchasers and clinical leaders.

How clinical innovation, decentralization of care, and evidence expectations are rapidly reshaping the competitive and operational landscape for inhaled nitric oxide solutions

The landscape for inhaled nitric oxide delivery is undergoing transformative shifts driven by convergence of clinical demand, technological innovation, and changes in care delivery models. Advances in electronic generator design have shifted expectations around portability, automated monitoring, and integration with electronic health records, thereby expanding potential use cases beyond the intensive care unit. Simultaneously, improvements in dosing precision and alarm systems have elevated safety benchmarks, prompting clinical teams to reassess traditional contraindications and explore earlier intervention strategies in select respiratory and cardiac contexts.

Concurrently, care decentralization is accelerating interest in devices suitable for ambulatory centers, home healthcare, and clinic-based programs. This movement is supported by growing emphasis on reducing hospital length of stay and readmission rates, which reorients decision-making toward devices that enable safe step-down care. Another notable shift is the maturation of integrated systems that combine delivery, monitoring, and supply management into single solutions, challenging the role of standalone devices and suppliers focused solely on gas cylinders. Finally, regulatory scrutiny and payer interest in demonstrating real-world clinical and economic value are prompting manufacturers to invest heavily in post-market evidence generation, outcomes research, and interoperability, creating a more evidence-driven commercialization environment.

Assessing the multifaceted operational and supply chain effects that United States tariff measures can exert on device sourcing, distribution, and procurement practices in 2025

Policy actions such as tariffs can reverberate across the inhaled nitric oxide ecosystem by altering component cost structures, import dynamics, and supplier bargaining power without necessarily changing the clinical rationale for use. When tariffs increase the landed cost of imported generators, cylinders, or electronic components, manufacturers often reassess sourcing strategies, which may include reshoring elements of production, diversifying supplier bases, or redesigning products to reduce dependence on tariff-exposed parts. These supply-side adaptations have downstream effects on procurement timelines and contract negotiations, as buyers seek longer lead times and clearer supply assurances.

Tariff-driven cost pressures also influence distribution strategies. Distributors and direct sales channels may recalibrate inventory policies and pricing models to preserve margins, which can temporarily constrain availability for certain hospital purchasing patterns. In parallel, higher input costs tend to accelerate adoption of technologies that reduce recurring expenditures, such as electronic generators that lower cylinder consumption or systems that enable intermittent dosing. From a regulatory and contracting perspective, public and private purchasers may seek greater transparency in origin of components as part of risk assessments, and contractual terms may increasingly include clauses addressing tariff pass-throughs or supply disruption contingencies. Collectively, these dynamics underscore the importance of proactive supply chain risk management and scenario planning to maintain continuity in clinical access.

Deep segmentation intelligence revealing how application, end user, technology, device type, channel, and delivery mode shape differentiated clinical and commercial strategies

Segmentation analysis reveals distinct clinical, operational, and commercial imperatives across application, end user, technology, delivery device type, distribution channel, and mode of delivery. Based on Application, market study spans Adult populations-where Hypoxemia in Cardiac Surgery and Pulmonary Hypertension represent divergent clinical pathways requiring different dosing strategies and monitoring intensity-as well as Neonatal populations where Hypoxemic Respiratory Failure and Persistent Pulmonary Hypertension of the Newborn demand highly sensitive control and rigorous safety features; Pediatric patients bridge these domains and often require devices adaptable to size and dosing complexity. Based on End User, the spectrum includes Ambulatory Care Centers and Clinics that prioritize throughput and ease of setup, Home Healthcare programs that emphasize portability and caregiver training, and Hospitals where integration with critical care systems and interoperability are paramount.

Based on Technology, options range from Cylinder Gas systems, which are familiar and widely deployed for their simplicity, to Electronic Generators that offer programmable dosing and reduced cylinder dependency; among Electronic Generators, distinctions between Fixed and Portable units drive placement decisions and influence procurement criteria. Based on Delivery Device Type, Integrated Systems that combine delivery and monitoring challenge traditional procurement processes, while Standalone devices can be attractive for modular deployments and retrofit scenarios. Based on Distribution Channel, Direct Sales arrangements support clinical training and contracting, Distributors can expand geographic reach and inventory support, and Online Channels provide a complementary route for ancillary products and consumables. Finally, based on Mode Of Delivery, Continuous therapies prioritize stability and long-term management capabilities, whereas Intermittent delivery requires robust titration features and rapid response monitoring. Together, these segmentation lenses inform tailored commercial strategies, clinical training requirements, and product roadmaps, underscoring that a one-size-fits-all approach is unlikely to meet the nuanced needs of diverse stakeholders.

Regional market dynamics and clinical adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence access, procurement, and commercialization

Regional dynamics materially influence clinical adoption patterns, reimbursement approaches, and the strategic priorities of manufacturers and distributors. In the Americas, strong academic medical centers and a concentration of cardiothoracic and neonatal specialty programs create focal points for early clinical adoption and real-world evidence generation, and procurement cycles often reflect integrated value assessments and negotiations with large health systems. As a result, there is heightened attention to device interoperability, service support models, and contractual terms that enable long-term clinical studies.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks, hospital procurement structures, and payer models vary widely across countries. In many European markets, centralized health technology assessment bodies and regional procurement consortia shape adoption decisions and require robust clinical and economic evidence. In parts of the Middle East and Africa, investment in tertiary care capacity is expanding, creating opportunities for suppliers that can provide comprehensive training and lifecycle support. Market entrants in this region commonly prioritize adaptable service models and locally compliant installation and maintenance capabilities.

Asia-Pacific exhibits rapid infrastructural growth in critical and neonatal care, coupled with an emphasis on domestic manufacturing in several countries. This combination yields a dual strategy for international suppliers: partnering with local manufacturers to navigate regulatory and procurement pathways, and offering differentiated products that address the demand for portable and easy-to-use devices in both urban tertiary centers and decentralized care settings. Across all regions, supply chain resilience, regulatory alignment, and evidence of clinical benefit remain core considerations in planning market access and commercial operations.

How leading manufacturers and service providers are differentiating through safety, evidence generation, and adaptable commercial models to secure clinical adoption

Leading companies active in the inhaled nitric oxide delivery space are investing across multiple fronts: engineering for safety and usability, building evidence packages that demonstrate clinical differentiation, and expanding service portfolios to support long-term device uptime. Technology leaders emphasize integration of monitoring, alarms, and interoperability with hospital information systems to reduce clinician burden and enable safer titration protocols. Competitors focused on gas-cylinder solutions maintain relevance by optimizing supply logistics and providing robust support networks for institutions where electronic generators have not yet achieved broad uptake.

Strategic behaviors include pursuing partnerships with clinical research networks to accelerate post-market surveillance and outcomes data, forming distribution alliances to broaden geographic reach, and pursuing modular product strategies that allow incremental upgrades without large capital replacement. Companies that excel in training and clinician engagement gain traction in neonatal and pediatric settings where operator familiarity and safety culture are critical. Meanwhile, firms that adopt flexible commercial models-leasing, managed services, and bundled consumable programs-strengthen relationships with health systems seeking predictable operating expenses. The competitive landscape is therefore characterized by a blend of technological differentiation, evidence generation, and service-oriented commercial models, each of which contributes to long-term adoption and customer retention.

Actionable strategic initiatives that industry leaders can implement to accelerate uptake, build resilience, and demonstrate clinical and economic value in complex healthcare systems

Industry leaders should prioritize a set of actionable initiatives to strengthen market position, enhance clinical impact, and reduce operational risk. First, invest in robust post-market evidence programs that measure not only physiological endpoints but also operational outcomes such as length of stay, readmission, and caregiver burden; these data will support reimbursement discussions and hospital procurement decisions. Second, develop flexible commercial models that align with customer preferences, including options for capital leasing, managed services, and outcomes-linked agreements that distribute risk and incentivize long-term partnerships. Third, enhance device interoperability and digital integration to reduce clinician workload and facilitate data capture for quality improvement initiatives.

In parallel, supply chain diversification is essential: map critical components, qualify alternative suppliers, and consider localized manufacturing or assembly to mitigate tariff exposure and logistical disruption. Strengthen training and credentialing programs targeted at neonatal and pediatric teams, as these areas are particularly sensitive to operator expertise and safety culture. Finally, collaborate with payers, hospital procurement groups, and clinical thought leaders to develop value narratives that articulate both clinical benefit and economic rationale, thereby smoothing pathways to adoption across varied care settings and geographies.

A rigorous mixed-methods research methodology blending primary clinical interviews, device technical analysis, and regulatory review to ensure balanced, actionable insights

This research employs a mixed-methods approach combining qualitative expert interviews, device specification analysis, regulatory literature review, and synthesis of peer-reviewed clinical evidence to produce an integrated view of the inhaled nitric oxide delivery landscape. Primary insights were derived from structured interviews with clinicians across neonatal, pediatric, and adult cardiopulmonary specialties, procurement leaders at acute and ambulatory care institutions, and senior executives at device manufacturers and distributors. These perspectives were triangulated with device technical documentation and regulatory filings to assess safety features, interoperability capabilities, and device classifications across jurisdictions.

Secondary analysis incorporated systematic review of clinical studies, guidelines, and consensus statements to contextualize application-specific requirements and safety considerations. Supply chain and commercial dynamics were evaluated through examination of public procurement frameworks, industry reports, and case studies of recent product launches and market entry strategies. Throughout the methodology, emphasis was placed on corroborating claims through multiple independent sources and prioritizing primary clinical input where discrepancies arose, ensuring that conclusions reflect a balanced synthesis of clinical relevance, technological capability, and operational feasibility.

Concluding synthesis that ties together clinical imperatives, technological trends, and organizational strategies to guide adoption and long-term planning

Inhaled nitric oxide delivery systems are positioned at an inflection point where clinical need, technology maturation, and shifting care delivery models intersect. The device landscape will continue to be shaped by demands for improved safety, greater portability, and demonstrable outcomes that justify broader use across ambulatory and home settings as well as traditional hospital environments. Manufacturers and suppliers that align product development with the operational realities of neonatal and adult critical care, while simultaneously investing in evidence generation and supply chain resilience, will be best placed to capture sustained clinical adoption.

For clinical leaders and procurement professionals, the imperative is to evaluate devices not only on immediate performance metrics but also on integration potential, training requirements, and lifecycle service commitments. Forward-looking strategies that combine technological differentiation, flexible commercial models, and proactive risk mitigation will enable organizations to deliver better patient outcomes at manageable total cost of care. Ultimately, the convergence of these elements will determine which technologies become standard of care across diverse clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Inhaled Nitric Oxide Delivery Systems Market, by Technology

  • 8.1. Cylinder Gas
  • 8.2. Electronic Generator
    • 8.2.1. Fixed
    • 8.2.2. Portable

9. Inhaled Nitric Oxide Delivery Systems Market, by Delivery Device Type

  • 9.1. Integrated Systems
  • 9.2. Standalone

10. Inhaled Nitric Oxide Delivery Systems Market, by Mode Of Delivery

  • 10.1. Continuous
  • 10.2. Intermittent

11. Inhaled Nitric Oxide Delivery Systems Market, by Application

  • 11.1. Adult
    • 11.1.1. Hypoxemia In Cardiac Surgery
    • 11.1.2. Pulmonary Hypertension
  • 11.2. Neonatal
    • 11.2.1. Hypoxemic Respiratory Failure
    • 11.2.2. Persistent Pulmonary Hypertension Of The Newborn
  • 11.3. Pediatric

12. Inhaled Nitric Oxide Delivery Systems Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Clinics
  • 12.3. Home Healthcare
  • 12.4. Hospitals

13. Inhaled Nitric Oxide Delivery Systems Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online Channels

14. Inhaled Nitric Oxide Delivery Systems Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Inhaled Nitric Oxide Delivery Systems Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Inhaled Nitric Oxide Delivery Systems Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Inhaled Nitric Oxide Delivery Systems Market

18. China Inhaled Nitric Oxide Delivery Systems Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Air Liquide S.A.
  • 19.6. Air Products and Chemicals, Inc.
  • 19.7. Air Water Inc.
  • 19.8. Bellerophon Therapeutics, Inc.
  • 19.9. Beyond Air, Inc.
  • 19.10. Chart Industries, Inc.
  • 19.11. Dragerwerk AG & Co. KGaA
  • 19.12. EKU Elektronik GmbH
  • 19.13. GE HealthCare Technologies Inc.
  • 19.14. Getinge AB
  • 19.15. INO Therapeutics LLC
  • 19.16. International Biomedical Ltd.
  • 19.17. Koninklijke Philips N.V.
  • 19.18. Linde plc
  • 19.19. Mallinckrodt Pharmaceuticals plc
  • 19.20. Medtronic plc
  • 19.21. Merck KGaA
  • 19.22. Messer Group GmbH
  • 19.23. NIOX Group plc
  • 19.24. Novoteris, LLC
  • 19.25. NU-MED Plus, Inc.
  • 19.26. SLE Ltd.
  • 19.27. Taiyo Nippon Sanso Corporation
  • 19.28. Teleflex Incorporated
  • 19.29. VERO Biotech LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 172. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 176. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 177. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 202. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 204. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 206. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 207. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 212. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 216. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 217. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)